Novartis AG - Depositary Receipt (Common Stock)
DE ˙ DB ˙ US66987V1098
121,00 € 0,00 (0,00%)
2026-06-04
AKTIENPREIS
SecurityDE:NOTA / Novartis AG - Depositary Receipt (Common Stock)
InstitutionAdvisory Resource Group
Latest Disclosed Ownership10,826 shares
Latest Disclosed Value $ 1,653,672
Advisory Resource Group reports 5.50% decrease in ownership of NOTA / Novartis AG - Depositary Receipt (Common Stock)

On May 15, 2026 - Advisory Resource Group filed a 13F-HR form disclosing ownership of 10,826 shares of Novartis AG - Depositary Receipt (Common Stock) (DE:NOTA) valued at $1,391,141 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 12, 2026 disclosing 11,456 shares of Novartis AG - Depositary Receipt (Common Stock). This represents a change in shares of -5.50% during the quarter. The current value of the position is $1,309,946 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F NOVARTIS SPONSORED ADR 66987V109 10,826 -630 -5.50 1,654 4.69 0.2846
2026-02-12 2025-12-31 13F NOVARTIS SPONSORED ADR 66987V109 11,456 114 1.01 1,579 8.60 0.2778
2025-10-22 2025-09-30 13F NOVARTIS SPONSORED ADR 66987V109 11,342 520 4.81 1,454 11.08 0.2609
2025-08-08 2025-06-30 13F NOVARTIS SPONSORED ADR 66987V109 10,822 150 1.41 1,310 10.09 0.2516
2025-04-21 2025-03-31 13F NOVARTIS SPONSORED ADR 66987V109 10,672 -736 -6.45 1,190 7.12 0.2423
2025-01-28 2024-12-31 13F NOVARTIS SPONSORED ADR 66987V109 11,408 -964 -7.79 1,110 -22.00 0.2356
2024-11-20 2024-09-30 13F NOVARTIS SPONSORED ADR 66987V109 12,372 -669 -5.13 1,423 2.52 0.3039
2024-07-24 2024-06-30 13F NOVARTIS SPONSORED ADR 66987V109 13,041 948 7.84 1,388 18.73 0.3133
2024-05-17 2024-03-31 13F NOVARTIS SPONSORED ADR 66987V109 12,093 4,797 65.75 1,170 58.83 0.2684
2024-01-11 2023-12-31 13F NOVARTIS SPONSORED ADR 66987V109 7,296 341 4.90 737 3.95 0.1837
2023-12-05 2023-09-30 13F NOVARTIS SPONSORED ADR 66987V109 6,955 212 3.14 708 4.12 0.1911
2023-07-11 2023-06-30 13F NOVARTIS SPONSORED ADR 66987V109 6,743 -829 -10.95 680 -2.30 0.1850
2023-05-15 2023-03-31 13F NOVARTIS SPONSORED ADR 66987V109 7,572 479 6.75 697 8.24 0.1954
2023-01-27 2022-12-31 13F NOVARTIS SPONSORED ADR 66987V109 7,093 3,496 97.19 643 135.53 0.1913
2022-10-11 2022-09-30 13F NOVARTIS SPONSORED ADR 66987V109 3,597 -43 -1.18 273 -11.36 0.0903
2022-07-21 2022-06-30 13F NOVARTIS SPONSORED ADR 66987V109 3,640 -496 -11.99 308 -15.15 0.1008
2022-04-06 2022-03-31 13F NOVARTIS SPONSORED ADR 66987V109 4,136 197 5.00 363 6.14 0.1130
2022-02-08 2021-12-31 13F NOVARTIS SPONSORED ADR 66987V109 3,939 613 18.43 342 25.74 0.1141
2021-10-26 2021-09-30 13F NOVARTIS SPONSORED ADR 66987V109 3,326 321 10.68 272 -0.73 0.1003
2021-08-19 2021-06-30 13F NOVARTIS SPONSORED ADR 66987V109 3,005 88 3.02 274 10.04 0.1096
2021-05-24 2021-03-31 13F NOVARTIS SPONSORED ADR 66987V109 2,917 262 9.87 249 -0.80 0.1163
2021-02-23 2020-12-31 13F NOVARTIS SPONSORED ADR 66987V109 2,655 194 7.88 251 17.29 0.1244
2020-12-09 2020-09-30 13F NOVARTIS SPONSORED ADR 66987V109 2,461 0 0.00 214 -0.47 0.1255
2020-08-19 2020-06-30 13F NOVARTIS SPONSORED ADR 66987V109 2,461 2,461 215 0.1326
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.